Pointe Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Pointe Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-302	Closed	-$174K	–	362
2023 Q1	$174K	Buy	+302	New	+$170K	0.13%	149
2022 Q1	–	Sell	-302	Closed	-$201K	–	158
2021 Q4	$201K	Buy	+302	New	+$189K	0.12%	148
2017 Q1	–	Sell	-3,720	Closed	-$525K	–	225
2016 Q4	$525K	Buy	+3,720	New	+$548K	0.3%	73

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Pointe Capital Management's TMO Position: Q2 2023 in Review

Pointe Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2023, closing a stake of 302 shares — an estimated $174K sold.

Pointe Capital Management first reported a position in TMO in Q4 2016 and held it in 3 quarters. The position peaked at $525K in Q4 2016. 2,387 funds tracked by Wall St. Rank hold TMO as of Q2 2023.

Pointe Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2023 after selling out during the quarter.
Pointe Capital Management sold 302 Thermo Fisher Scientific shares in Q2 2023, an estimated $174K.
Pointe Capital Management first reported a position in Thermo Fisher Scientific in Q4 2016 and held it in 3 quarters.
Pointe Capital Management's Thermo Fisher Scientific position peaked at $525K in Q4 2016.
2,387 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2023.

Based on Pointe Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.